Low CD34+ Cell Doses Are Associated with Increased Cost and Worse Outcome after Tandem Autologous Stem Cell Transplantation in Patients with Relapsed or Refractory Germ Cell Tumors-Reference-Cited by-同舟云学术

Low CD34+ Cell Doses Are Associated with Increased Cost and Worse Outcome after Tandem Autologous Stem Cell Transplantation in Patients with Relapsed or Refractory Germ Cell Tumors

Published:2018-07 Issue:7 Volume:24 Page:1497-1504
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Hyder Mustafa A.,Goebel W. Scott,Ervin Kirsten D.,Schwartz Jennifer E.,Robertson Michael J.,Thakrar Teresa C.,Albany Costantine,Farag Sherif S.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference20 articles.

1. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers;J Clin Oncol,1997

2. Medical treatment of advanced testicular cancer;Feldman;JAMA,2008

3. High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors;Einhorn;N Engl J Med,2007

4. High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: an Eastern Cooperative Oncology Group protocol;Nichols;J Clin Oncol,1992

5. Dose-intensive chemotherapy in refractory germ cell cancer—a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation;Nichols;J Clin Oncol,1989

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recombinant human thrombopoietin improves platelet engraftment after autologous hematopoietic stem cell transplantation in patients with aggressive lymphoma;Transfusion and Apheresis Science;2024-10

2. Recombinant human thrombopoietin improves platelet engraftment after autologous hematopoietic stem cell transplantation in patients with aggressive lymphoma;2023-08-07

3. Effect of Autograft CD34+ Dose on Outcome in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System Tumors;Transplantation and Cellular Therapy;2023-06

4. Plerixafor and granulocyte colony stimulating factor for poor mobilizers in patients undergoing autologous peripheral hematopoietic stem cell transplantation: Single institution study;Frontiers in Transplantation;2023-01-18

5. Development and validation of a predictive model to guide the use of plerixafor in pediatric population;Bone Marrow Transplantation;2022-09-26